Basseterre, St. Kitts, February 12, 2021 (SKNIS): St. Kitts & Nevis’ Chief Medical Officer, Dr. Hazel Laws, said that the procurement in the first instance of 21, 600 doses of the COVID-19 Vaccine, will provide coverage for 20 percent of the national population.
She said this during the National Emergency Operations Center (NEOC) COVID-19 Press Briefing on February 10. “The doses are the product of AstraZeneca and Oxford University vaccines,” she said.
“The start date for delivery can be as early as mid to late February, however, there were some conditions where the specific date of delivery would be dependent on the WHO Emergency Use List Approval Process and some other steps which include our own implementation of our vaccination plan and our regulatory preparedness,” said Dr. Laws.
“It specified that about 25 – 35% of the amount will be supplied in the first quarter and about 65-75% in the second quarter,” she said.
“The data from the clinical trials suggest that it offers a 62 percent efficacy, but the clinical trials have since found that the vaccine had an efficacy of about 82 percent when two doses were given 12 weeks apart,” said Dr. Laws.
Monday, September 7
Trending
- “Learn Today; Lead Tomorrow”: Education Minister Sets The Tone For the 2026-2027 Academic Year
- Historic ‘Ancestral Echoes’ Commemoration Unites Nations in Solemn Reflection and Healing on 400th Anniversary
- STATEMENT FROM THE CABINET SECRETARIAT: HEALTH UPDATE ON PRIME MINISTER THE HON. DR. TERRANCE M. DREW
- STAKEHOLDERS MAP OUT NEW WASTE MANAGEMENT AND RECYCLING STRATEGIES
- Solid Waste Management Outcome Report: St. Kitts and Nevis Advances Sustainable Waste Management Strategy with Taiwan Partnership
- STATEMENT ON THE HEALTH OF PRIME MINISTER THE HON. DR. TERRANCE M. DREW
- Permanent Mission of St. Kitts and Nevis to the UN Joins Engagement with Taiwan Youth Ambassadors, Advancing People-to-People Connections
- Ministry of Justice Advances Criminal Mediation through Phase II Practitioner Training

